Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Genprex, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −7 vs. Q2 2025
- Shares held
- 1.36M
- +686.6K (+102.4%) vs. Q2 2025
- Total value
- $229.5K
- +$76.6K (+50.1%) vs. Q2 2025
- New holders
- 1
- 7 more added
- Sold out
- 8
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $154.9K |
| Q1 2026 | 27 | $169.0K |
| Q4 2025 | 22 | $13.0K |
| Q3 2025 | 21 | $229.5K |
| Q2 2025 | 28 | $152.9K |
| Q1 2025 | 24 | $93.5K |
| Q4 2024 | 22 | $247.0K |
| Q3 2024 | 21 | $79.7K |
| Q2 2024 | 15 | $510.3K |
| Q1 2024 | 17 | $426.0K |
| Q4 2023 | 36 | $1.16M |
| Q3 2023 | 39 | $2.61M |
| Q2 2023 | 38 | $3.64M |
| Q1 2023 | 39 | $5.42M |
| Q4 2022 | 45 | $5.84M |
| Q3 2022 | 43 | $6.29M |
| Q2 2022 | 42 | $6.11M |
| Q1 2022 | 50 | $10.8M |
| Q4 2021 | 47 | $9.78M |
| Q3 2021 | 49 | $15.8M |
| Q2 2021 | 59 | $19.5M |
| Q1 2021 | 72 | $35.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Genprex, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 63 | $0 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 25 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5 | $1 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 5 | $1 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 24 | $4 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 125 | $22 | 0.00% | 00.0% | Unchanged |
| Nemes Rush Group LLC | 250 | $42 | 0.00% | 00.0% | Unchanged |
| HighMark Wealth Management LLC | 500 | $85 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 715 | $121 | 0.00% | +38+5.6% | Added |
| Morgan Stanley | 958 | $162 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 2,421 | $410 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,808 | $984 | 0.00% | −180−3.0% | Reduced |
| Citigroup Inc | 6,084 | $1.03K | 0.00% | −6,522−51.7% | Reduced |
| Advisor Group Holdings, Inc. | 8,610 | $1.39K | 0.00% | +8,500+7,727.3% | Added |
| BlackRock, Inc. | 9,391 | $1.59K | 0.00% | −94−1.0% | Reduced |
| TCG Advisory Services, LLC | 17,000 | $2.88K | 0.00% | +1,500+9.7% | Added |
| UBS Group AG | 162,202 | $27.4K | 0.00% | +30,963+23.6% | Added |
| Geode Capital Management, LLC | 164,027 | $27.8K | 0.00% | +88,823+118.1% | Added |
| Jane Street Group, LLC | 205,180 | $34.8K | 0.00% | +205,180 | New |
| Susquehanna International Group, LLP | 340,056 | $57.6K | 0.00% | +35,661+11.7% | Added |
| Vanguard Group Inc | 433,369 | $73.2K | 0.00% | +418,054+2,729.7% | Added |
| Virtu Financial LLC | 0 | $0 | 0.00% | −43,103−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −21,540−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −16,580−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Mount Yale Investment Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Curio Wealth, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −5−100.0% | Sold out |